Gibson Dunn Advising XOMA Royalty on XenoTherapeutics and Xeno Acquisition’s Purchase of Repare Therapeutics
Firm News | November 19, 2025
Gibson Dunn is advising XOMA Royalty on XenoTherapeutics, Inc. and Xeno Acquisition Corp.’s acquisition of Repare Therapeutics Inc.
Our corporate team is led by partners Ryan Murr and Branden Berns and includes associates Evan Shepherd, Lauren Guzman, and Jonvieve Anderson. Partner Pamela Lawrence Endreny and associate Elizabeth Johnson are advising on tax aspects. Partner Sean Feller is advising on benefits.